3b blackbio

[Stock note]: 3B Black Bio…Fast Growing, high margin business of Molecular Diagnostic Kits Inbox

In the last 1 year, the broader markets are down around 15-20%. What’s good though is that investor’s sentiment and participation is also down as reflected by Google trends data and avg. daily turnover data of NSE. While near term portfolio returns can remain subdued, it’s a great time for stock picking and portfolio restructuring. Those who will invest in growth stocks trading at reasonable valuations today, will probably make great returns on portfolio over the next 3-5 years. Today, we will look…

Read More

[Stock note] – 3B Blackbio DX…rapidly growing Molecular Diagnostic company

I was recently reading about 3B Blackbio DX. For sometime, it has been under our radar because of its Diagnostic kits business – TRUPCR. This company was reporting 25-30 crore annual sales before Covid-19; however, in FY 21 its sales jumped up to Rs 227 crore with PAT of Rs 114 crore. With the normalization of Covid-19 impact, the company is again on a growth path with annual sales of Rs 90 crore. Below, we have shared points from the Nov’24 presentation of…

Read More

[Stock note] – 3B Blackbio DX…fast growing company in the Diagnostic space

Hello Sir, Hope you are doing well. We have always enjoyed digging up really small companies in the market cap range of Rs 200 crore to Rs 1,000 crore. Earlier, we could even recommend a Rs 100 crore market cap stock to our (opens in new tab)Premium Members; however, now it’s almost impossible considering liquidity issues. For sometime, 3B Blackbio DX, formerly Kilpest India has been under our radar because of its Diagnostic kits business – TRUPCR. This company was reporting 25-30 crore…

Read More